WASHINGTON (AP) - A rising PSA level isn't such a good predictor of prostate cancer after all and can lead to many unnecessary biopsies, says a large new study. Most men over 50 get PSA blood tests, ...
The researchers found 13 participants (26%) had a 50% or higher decline in PSA from baseline (PSA50); all were within the homologous recombination repair-positive group (13 of 27; 48%). (HealthDay ...
Millions of men are tested each year for high levels of prostate-specific antigen, or PSA, which is designed to detect early signs of prostate cancer. The test is covered by insurance, so most men ...
DEAR DR. ROACH: I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family history of prostate cancer. During my most recent yearly ...
Dear Dr. Roach: I am 65 and have been taking 5 mg of finasteride for over one year to address benign prostatic hyperplasia (BPH). My PSA score has lowered from 11.4 ng/mL (before finasteride) to 7.9 ...
The National Comprehensive Cancer Network and the American Urological Association currently recommend that men who have a spike in prostate specific antigen (PSA) levels get a biopsy to test for ...
Dr. Keith Roach writes a medical question-and-answer column weekdays. Dear Dr. Roach: Some 20 years ago, as I was turning 50, a biopsy confirmed prostate cancer. I elected to deal with that through ...
UC Davis just announced a seminar for the public on "men's health." That title notwithstanding, the program appears to be entirely about prostate cancer and in particular about the prostate specific ...
Come December, as I observe my "pros-mitzvah" -- 13 years on active surveillance (AS) for very low-risk prostate cancer -- I feel I'm at a tipping point. Should I stay the course and keep monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback